ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Complicated Cases Discussed in Pediatric Thieves Market

Thomas R. Collins  |  Issue: December 2025  |  November 14, 2025

On genetic testing, the girl was found to have a variant of the IFITm5 gene, which can cause osteogenesis imperfecta V, a disease in which bones are susceptible to easy fracture.

She was managed with zoledronate, calcium and vitamin D supplements.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Nameirakpam said the disease can mimic inflammatory arthritis, so caution is needed.

“So don’t go into your knee-jerk reflex of starting DMARDs [disease-modifying anti-rheumatic drugs] when we have some arthritis or arthritis-like picture,” he said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

19-Year-Old Male with a Worsening Headache

Rasha Elrefai, MD, a pediatric rheumatology fellow at Baylor College of Medicine, Houston, discussed a 19-year-old male with a worsening headache and vision and memory issues whose health challenges began early in life. He had Evans syndrome and recurrent infections at age 2; erythema nodosum and necrotizing granuloma on lymph node biopsy at age 3; enteritis, colitis, immune dysregulation and T cell lymphopenia at age 15; and panuveitis and bilateral cataracts at age 17.

A physical exam showed short stature, flexion deformities in both hands, an eczematous rash along the elbows and a right-sided visual field deficit. His inflammatory markers were elevated, with mild leukocytosis, as well as lymphopenia and thrombocytopenia.

A brain MRI showed left posterior circulation artery infarction, which was concerning for stroke. A CT angiography of the head showed chronic injury with encephalomalacia in the posterior inferior left parietal lobe.

He was positive for antiphospholipid antibodies and began to have clinical seizure episodes, and he was given triple antiepileptic therapy, Dr. Elrefai said.

After a rheumatology consult, hydroxychloroquine was started and his mycophenolate mofetil dosing was optimized.

He was found to have immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia (IMD-71), a rare disorder caused by a mutation in the ARPC1B gene, which is critical for regulating the actin cytoskeleton in immune cells. Deficiency of this gene leads to impaired T cell and B cell function, Dr. Elrefai said. Hematopoietic stem cell transplant is considered feasible and effective for the condition, she said.

She said the disorder can initially resemble systemic lupus erythematosus.

“Molecular diagnostics,” Dr. Elrefai said, “are crucial for distinguishing monogenic immune dysregulation disorders from acquired or idiopathic autoimmune conditions, fundamentally altering treatment approaches.”


Thomas R. Collins is a freelance medical writer based in Florida.

References

  1. Conticini E, d’Alessandro M, Al Khayyat SG, et al. Inflammatory muscle involvement in systemic vasculitis: A systematic review. Autoimmun Rev. 2022 Mar;21(3):103029.
  2. Lacou M, Leroy M, Lan NL, et al. Muscle biopsy in anti-neutrophil cytoplasmic antibody-associated vasculitis: Diagnostic yield depends on anti-neutrophil cytoplasmic antibody type, sex and neutrophil count. Rheumatology (Oxford). 2021 Feb 1;60(2):699–707.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2025case reportpatient carepediatric conditions

Related Articles

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    Myositis Mysteries

    January 1, 2008

    Why isn’t my myositis patient getting better?

    Tashatuvango / shutterstock.com

    Myositis-Specific Antibodies Identified

    January 16, 2020

    The idiopathic inflammatory myopathies (IIM) encompass eight categories: 1) dermatomyositis (DM) in adults, 2) juvenile dermatomyositis, 3) amyopathic DM, 4) cancer-associated DM, 5) polymyositis, 6) immune-mediated necrotizing myopathy, 7) inclusion body myositis, and 8) overlap myositis.1 These categories help classify the myopathies based on clinical and histologic features. The incidence of IIM is estimated at…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences